NCT07606651

Brief Summary

The goal of this observational study is to learn about the impact of low-level blast exposure in U.S. Special Operations Forces personnel. The main questions it aims to answer are: What advanced brain imaging changes are related to clinical presentation after low-level blast exposure? What are the relationships between low-level blast exposure and common groups of symptoms after concussion? Participants will:

  • Undergo advanced brain imaging
  • Answer questionnaires
  • Complete clinical tests
  • Provide blood, urine, and saliva samples
  • Wear blast sensors

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
50mo left

Started May 2026

Longer than P75 for all trials

Geographic Reach
1 country

3 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
May 2026Aug 2030

First Submitted

Initial submission to the registry

March 24, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
25 days until next milestone

First Posted

Study publicly available on registry

May 26, 2026

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2030

Last Updated

May 26, 2026

Status Verified

March 1, 2026

Enrollment Period

4.3 years

First QC Date

March 24, 2026

Last Update Submit

May 18, 2026

Conditions

Keywords

traumatic brain injuryconcussionmagnetic resonance imagingblast overpressurelow-level blast exposurerepeated blast exposure

Outcome Measures

Primary Outcomes (1)

  • Effective axonal radii mapping

    The primary outcome measure in this study will be effective axonal radii (r\_eff) mapping derived from ultra-high performance diffusion magnetic resonance imaging using the MAGNUS system and its correlations to low-level blast exposure.

    At baseline and annually through study completion, an average of 5 years

Secondary Outcomes (32)

  • Ohio State University TBI Identification Method

    At baseline and annually through study completion, an average of 5 years

  • Concussion Clinical Profiles Screening

    At baseline and annually through study completion, an average of 5 years

  • Neurobehavioral Symptom Inventory

    At baseline and weekly through study completion, an average of 5 years

  • Headache Impact Test

    At baseline and weekly through study completion, an average of 5 years

  • modified Military Concussion Readiness Inventory for Dizziness and Balance

    At baseline and quarterly through study completion, an average of 5 years

  • +27 more secondary outcomes

Other Outcomes (3)

  • quantitative EEG via the NeuroCatch®

    At baseline and quarterly through study completion, an average of 5 years

  • Blast sensor-measurement of blast exposure(s)

    Daily through study completion, an average of 5 years

  • Self-report of blast exposure(s)

    Daily through study completion, an average of 5 years

Study Arms (2)

High exposure (experimental)

Special Operations Forces personnel with higher occupational blast overpressure exposure as measured by blast sensor(s)

Low/No exposure (control)

Special Operations Forces personnel with lower occupational blast overpressure exposure as measured by blast sensor(s)

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The target population is 250 SOF personnel, particularly those who are regularly exposed to occupational low-level blast exposure. Approximately 10% of the sample will be recruited as a control group of low/no exposure personnel.

You may qualify if:

  • Active duty
  • U.S. SOF personnel
  • years old

You may not qualify if:

  • Subjects will be excluded only if their participation will significantly interfere with validity of data collection or safety during the study (e.g., they have conditions that might result in harm or injury during research procedures).
  • Example: pregnancy (balance considerations)
  • Example: being unable to undergo MRI testing (i.e., they have non-MRI compatible devices, imbedded metal fragments such as shrapnel, and/or severe claustrophobia; these MRI contraindications will be screened using an MRI Safety Questionnaire)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Walter Reed National Military Medical Center

Bethesda, Maryland, 20889, United States

Location

Fort Bragg

Fort Bragg, North Carolina, 28310, United States

Location

Wilford Hall Ambulatory Surgical Center

San Antonio, Texas, 78236, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

blood; saliva; urine

MeSH Terms

Conditions

Brain Injuries, TraumaticBrain Concussion

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesHead Injuries, ClosedWounds, Nonpenetrating

Study Officials

  • Vincent B Ho, MD

    Uniformed Services University of the Health Sciences

    STUDY CHAIR
  • Tony T Yuan, PhD

    Uniformed Services University of the Health Sciences

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tony T Yuan, PhD

CONTACT

Carrie W Hoppes, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 24, 2026

First Posted

May 26, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

August 1, 2030

Study Completion (Estimated)

August 1, 2030

Last Updated

May 26, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Research data may be shared, when permitted by USSOCOM, upon reasonable request to the Principal Investigator.

Locations